Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lilly's Humalog reaches first market

June 21, 1996

Teikoku Hormone reveals novel octadecapeptide

June 21, 1996

Lilly discloses insulin analogues

June 21, 1996

Ceredase approved in Japan

June 21, 1996

Redux launched in U.S.

June 21, 1996

Research results of SomatoKine as catabolism treatment

June 21, 1996

Astra acquires worldwide rights to ALX1-11

June 21, 1996

Orquest's Healos enters clinical trials

June 21, 1996

Calcium receptor modulators from NPS Pharm.

June 21, 1996

Vivus and Astra sign Muse licensing agreement

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...